Merck & Co. Inc. buy BMO Capital Markets
Start price
01.11.24
/
50%
€94.50
Target price
01.11.25
€125.35
Performance (%)
-20.95%
End price
02.11.25
€74.70
Summary
This prediction ended on 02.11.25 with a price of €74.70. The prediction for Merck & Co. Inc. disappointed with a performance of -20.95%. BMO_Capital_Markets has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -0.595% | -0.595% | 15.172% |
| iShares Core DAX® | -1,10 % | -6,08 % | 0,87 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 18,26 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 26,34 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 13,29 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at BMO Capital Markets from $150.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€85.40
18.12.25
18.12.25
€110.75
18.12.26
18.12.26
17.33%
16.03.26
16.03.26
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€101.00
27.10.23
27.10.23
€125.02
27.10.24
27.10.24
-4.06%
28.10.24
28.10.24